These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2547134)

  • 41. The Royal College of Radiologists' Clinical Oncology Information Network. Guidelines on the non-surgical management of breast cancer.
    Clin Oncol (R Coll Radiol); 1999; 11(3):S90-133. PubMed ID: 10465465
    [No Abstract]   [Full Text] [Related]  

  • 42. Effective treatment of ductal carcinoma in situ with a HER-2- targeted alpha-particle emitting radionuclide in a preclinical model of human breast cancer.
    Yoshida T; Jin K; Song H; Park S; Huso DL; Zhang Z; Liangfeng H; Zhu C; Bruchertseifer F; Morgenstern A; Sgouros G; Sukumar S
    Oncotarget; 2016 May; 7(22):33306-15. PubMed ID: 27119227
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Breast conservation therapy for intraductal carcinoma of the breast.
    Kuske RR; Bean JM; Garcia DM; Perez CA; Andriole D; Philpott G; Fineberg B
    Int J Radiat Oncol Biol Phys; 1993 Jun; 26(3):391-6. PubMed ID: 8390417
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Combination of anti-estrogenic therapy with radiation in breast cancer: simultaneous or sequential treatment?
    Schmidberger H; Hermann RM; Hess CF; Emons G
    Onkologie; 2005 May; 28(5):275-80. PubMed ID: 15867485
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The problem of ductal carcinoma in situ of the breast.
    Fentiman IS
    Ann Chir Gynaecol; 1992; 81(4):334-6. PubMed ID: 1336650
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Conservative surgery and radiation for intraductal breast carcinoma.
    Moss WT
    JAMA; 1992 Jul; 268(2):266. PubMed ID: 1318979
    [No Abstract]   [Full Text] [Related]  

  • 47. [Methylation of Runx3 promoter in different breast lesions].
    Wang X; Zheng X; Lin X; Shi Y; He Y; Chen G
    Zhonghua Bing Li Xue Za Zhi; 2014 Jul; 43(7):447-50. PubMed ID: 25327792
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Ductal carcinoma in situ of the breast (DCIS) under 40: a specific management?].
    Cutuli B
    Gynecol Obstet Fertil; 2008 Jun; 36(6):705-6. PubMed ID: 18539513
    [No Abstract]   [Full Text] [Related]  

  • 49. [Comparison of lectin receptor and carcinoembryonic antigen in the cancerous and non-cancerous tissues in the human breast].
    Zheng Z
    Zhonghua Zhong Liu Za Zhi; 1992 Sep; 14(5):353-6. PubMed ID: 1337891
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Diagnosis and treatment of breast cancer].
    Winzer KJ
    Chirurg; 2005 Aug; 76(8):803-16; quiz 817-8. PubMed ID: 15999267
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Current controversies in the treatment of ductal carcinoma in situ of the breast.
    Franceschini G; Terribile D; Magno S; Fabbri C; D'Alba P; Chiesa F; Di Leone A; Scafetta I; Masetti R
    Ann Ital Chir; 2008; 79(3):151-5. PubMed ID: 18958961
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The in vivo uptake of tritiated estradiol in carcinoma of the breast.
    Viladiu P
    Surg Gynecol Obstet; 1975 Apr; 140(4):544-6. PubMed ID: 165580
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer.
    Allred DC; Clark GM; Molina R; Tandon AK; Schnitt SJ; Gilchrist KW; Osborne CK; Tormey DC; McGuire WL
    Hum Pathol; 1992 Sep; 23(9):974-9. PubMed ID: 1355464
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bilateral breast carcinoma treated with definitive irradiation.
    Solin LJ; Fowble BL; Schultz DJ; Goodman RL
    Int J Radiat Oncol Biol Phys; 1989 Aug; 17(2):263-71. PubMed ID: 2546905
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Therapy of pronounced pleural and pericardial effusion in metastatic breast cancer with local mitoxantrone and radiation therapy. Presentation of the intrapleural cytologic findings during this therapy].
    Blohmer JU; Kohls A; Lau HU
    Zentralbl Gynakol; 1993; 115(2):86-9. PubMed ID: 8383901
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human in-vivo 31P MR spectroscopy of benign and malignant breast tumors.
    Park JM; Park JH
    Korean J Radiol; 2001; 2(2):80-6. PubMed ID: 11752975
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Levels of phospholipid metabolites in breast cancer cells treated with antimitotic drugs: a 31P-magnetic resonance spectroscopy study.
    Sterin M; Cohen JS; Mardor Y; Berman E; Ringel I
    Cancer Res; 2001 Oct; 61(20):7536-43. PubMed ID: 11606391
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An adequate margin of excision in ductal carcinoma in situ.
    Kell MR; Morrow M
    BMJ; 2005 Oct; 331(7520):789-90. PubMed ID: 16210257
    [No Abstract]   [Full Text] [Related]  

  • 59. Psoriasis and radiotherapy.
    Tomlinson MJ
    Clin Oncol (R Coll Radiol); 2001; 13(2):145. PubMed ID: 11565503
    [No Abstract]   [Full Text] [Related]  

  • 60. Responsiveness of adjacent ductal carcinoma in situ and changes in HER2 status after neoadjuvant chemotherapy/trastuzumab treatment in early breast cancer--results from the GeparQuattro study (GBG 40).
    von Minckwitz G; Darb-Esfahani S; Loibl S; Huober J; Tesch H; Solbach C; Holms F; Eidtmann H; Dietrich K; Just M; Clemens MR; Hanusch C; Schrader I; Henschen S; Hoffmann G; Tiemann K; Diebold K; Untch M; Denkert C
    Breast Cancer Res Treat; 2012 Apr; 132(3):863-70. PubMed ID: 21667238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.